Health funding

Enveda is an AI drug discovery startup that has raised $311 million, reaching a $2 billion valuation. The company leverages AI to accelerate the drug discovery process.

Octin Health is developing a novel approach to aortic arch surgery. The company has raised $2.5 million to advance its technology, which aims to provide a less invasive and more effective solution for patients requiring this complex procedure.

Novadip Biosciences is a Belgian late-stage clinical biotech company specializing in regenerative medicine. They have developed a proprietary platform using adipose-derived stem cells to create tissue for healing bone defects and fractures. This funding will support their pivotal Phase 3 clinical trial for NVD003 and preparation for regulatory submission in the United States.

MozartAI is a healthtech automation company that has raised $10 million in seed funding. The company aims to bring its automation solutions to the Mexican market, potentially improving efficiency and accessibility within the healthcare sector.

Disha is a vernacular AI health coaching platform offering personalized diet, fitness, and chronic-care support across 15 conditions. The platform operates in Hindi, English, and Hinglish, providing automated coaching. This Series A funding will be used for working capital, proprietary AI model development, and business expansion.

AbTx is a French biotechnology startup founded in 2024, developing a new generation of antibody-drug conjugates (ADCs) for solid tumors. Their patented Therano-Stick platform uses enzymatic bio-conjugation to create miniaturized ADCs called fragment drug conjugates (FDCs). This seed round aims to validate their novel platform in the competitive ADC field.

Piomic, a Swiss medtech startup spun out of ETH Zurich, develops physical stimulation therapies for deep tissue regeneration. Their lead product, the COMS One Therapy System, is a portable, non-invasive device for treating non-healing wounds. This $25 million growth round will fund clinical trials, US market approval filing, and expansion into new applications.

Penelope Health is a real-time provider and payer policy intelligence platform that aims to bring administrative efficiency to navigating payer requirements in healthcare. They convert complex data into a single infrastructure layer for healthcare companies to check coverage requirements and compare policies across payers. This funding will support the creation of new products to streamline these processes.

Aseptuva is a Swiss-UK Medtech startup developing a targeted Far-UVC disinfection technology to prevent hospital-acquired infections, particularly bloodstream infections associated with intravenous catheters. Their technology aims to reduce infection risk and antibiotic reliance by disinfecting at the catheter-entry site. The company is focused on preventing deaths, shortening hospital stays, and reducing healthcare costs.

Phosphoenix is an Amsterdam-based MedTech startup developing a neuroprosthetic system for people with profound blindness. Their system uses a proprietary Fountain Probe with over 1,000 microelectrodes to directly stimulate the brain's visual pathway, bypassing damage to the eyes. This €1.3 million financing round will support preparations for their first-in-human clinical study and further development of their neurostimulation system.

Wysa is an AI-powered mental health chatbot that provides emotional support and therapeutic exercises. The company aims to make mental wellness accessible and affordable for everyone. This funding will help Wysa expand its services and reach more users globally.

Vytalyou is a longevity healthcare startup. The company has raised growth funding to expand its services and reach. This funding round aims to support the startup's continued development in the growing longevity market.

Eterna Regeneratives is a London-based startup developing a biomaterials platform to regenerate human tooth enamel. Their patented material, derived from keratin in sheep's wool and human hair, can be incorporated into toothpaste for enduring enamel repair. The company is targeting the global oral care market with its innovative approach.

TRUE ARTIS is an integrated Indian aesthetic healthcare and surgical platform offering procedures across facial aesthetics, breast surgery, body contouring, and hair restoration. The company aims to build a new category in aesthetic healthcare by focusing on clinical care, patient safety, transparency, and patient experience. This seed funding will be used to expand operations in Delhi NCR, strengthen capabilities, and develop technology.

Waspito is a Cameroonian e-health startup that connects users with medical doctors via instant video consultations from their smartphones. It also provides mobile laboratory services, allowing lab technicians to collect samples from users' homes and deliver results digitally.

Nara Health is a Chicago-based health insurance startup that aims to provide innovative health insurance solutions. The company focuses on improving access to healthcare for individuals and families, making it easier for them to navigate their health insurance options. This funding round will help Nara Health expand its offerings and reach more customers.

Aware Health was a company focused on making preventive health a part of everyday life through whole-body MRI and recurring blood diagnostics. The company aimed to build healthier societies and more effective healthcare systems. It has been acquired by Aeon, a European company in the preventive health space.

Elita is a canine health startup focused on preventative care, offering genetic banking, at-home tests, and 24/7 telehealth services. They are developing technology called Blueprint to track a dog's health over time. The company aims to make preventative care more accessible and improve the standard of care for dogs.

A new cancer biotech company has been launched by the former CEO of Mural Oncology. The company has secured $225 million in venture capital funding to advance its cancer research and development efforts.

Deep Connection Innovation Pvt Ltd is a pediatric neurodevelopment startup using AI-native infrastructure to detect and manage developmental delays and disorders in children. They aim to shift the detection window from age 5 to 1.5 years, believing early intervention during peak brain neuroplasticity is crucial for better long-term outcomes. The company operates a hybrid model combining a digital AI platform with physical child development centers, with its flagship 'FitQuest' program designed for schools, homes, and community settings.

Absci Corporation is a biotechnology company developing ABS-201, a drug for pattern hair loss and endometriosis. The company announced positive early clinical trial data for ABS-201, showing it was well-tolerated and had a long-lasting presence in the body. This news coincided with a $100 million stock offering to fund further development.

Fertally is a Wexford-based fertility tech startup that uses individualised algorithms built from wearable data, indexed against their research database, and shared with clinicians to personalize fertility care. They are planning a €500k funding round later this year to improve upon traditional fertility treatments that rely on population averages.

iPremom is a health technology company that provides a platform for pregnancy tracking and related services. It targets expectant mothers looking for tools to monitor their pregnancy journey. The recent €15M seed funding will help enhance their offerings and expand their market reach.

Ultrahuman is a health and fitness technology company that focuses on providing personalized health insights and fitness solutions. The company aims to enhance the wellness experience for consumers through innovative technology and data-driven insights. This funding round will help Ultrahuman expand its offerings and reach a broader audience.

ENA Respiratory is a clinical-stage biotech company developing an antiviral nasal spray, INNA-051, to strengthen the body's first line of defense against respiratory viruses like influenza, RSV, and COVID-19. This $3 million grant will fund a trial in adults with asthma to assess the treatment's safety and efficacy, aiming to reduce complications from respiratory infections in high-risk groups.

PatientIQ is a Chicago-based healthcare software startup that provides solutions for patient data management and analysis. The company focuses on leveraging AI to accelerate growth and improve outcomes in the healthcare sector. This funding round will support their continued development and expansion.

Tensive is developing an alternative to traditional breast implants. The company has received a €20 million loan from the European Investment Bank (EIB) to advance its REGENERA technology.

Strolll is a UK-based MedTech company that has secured funding to advance its operations. The specific details of their technology and market focus are not provided in the article.

The Wellness Company is a Toronto-based consumer healthtech startup that is transforming its collection of individual wellness apps into a connected health platform centered around its AI-powered companion, Tempo. Tempo integrates data from various wellness apps, wearables, and user inputs to create personalized health plans and track progress towards user goals. The company aims to leverage its existing user base and recurring revenue to shift towards a more unified product offering.

Superluminal Medicines is a biotechnology company using AI and machine learning for drug discovery. They focus on rare genetic forms of obesity and hypothalamic obesity. This Series B funding will advance their lead program for rare genetic forms of obesity toward a first clinical trial.

Thyme Care is a cancer care startup that focuses on improving patient treatment through a virtual navigation platform. The company aims to address gaps in cancer care, including drug affordability and clinical trial access, and has expanded its services to over 10.5 million people across the U.S.

DocPharma is a prescription compliant quick commerce supply chain platform for healthcare. It operates a network of licensed dark stores and a SaaS platform that supports over 30 healthcare and wellness platforms in delivering medicines and healthcare products. The company aims to expand its operations significantly with the new funding.

GonGlobal is a biotech startup focused on developing needle-free IVF treatments to improve the patient experience. The company aims to replace traditional drug injections with an inhaler platform, making fertility treatments less invasive and more accessible. This funding round will accelerate the development of their Ovulair drug delivery system.

Norbert Health develops autonomous robotic nursing assistants aimed at improving patient care. The company targets healthcare facilities looking to enhance their nursing capabilities with innovative technology. This funding round will help accelerate the development and deployment of their robotic solutions.

Stack Health is a startup that helps small businesses shift from traditional group health insurance to individual coverage plans for their employees. They utilize an ICHRA model, allowing employers to provide a fixed contribution that employees can use to select personalized health plans. This approach aims to give businesses more control over their benefits spending and employees greater choice and flexibility in their healthcare.

Chiasma is a biopharmaceutical company focused on developing oral therapies for rare diseases, specifically acromegaly. The company aims to provide a more patient-friendly alternative to existing injectable treatments, which are often painful and inconvenient. Despite recent setbacks, Chiasma is preparing to submit trial results to the FDA and seeks to launch its product in the near future.

EIT Pharma is a company focused on developing innovative pharmaceutical solutions. The company aims to address unmet medical needs in various therapeutic areas. This funding round will help accelerate their product development and market entry.

CRNA is focused on enhancing gene expression, achieving up to a 60x boost. The company has established over 20 collaborations and has raised NOK 620 million to support its growth through 2030.

Aeris Biosciences is focused on developing innovative wound care technologies. The company aims to bring its advanced solutions to the human market, addressing significant needs in wound management. This funding round will support their efforts to commercialize their technology.

KOVE medical is a femtech company focused on developing innovative medical solutions for women's health. The company is preparing for its First in Human study following a successful seed funding round. This funding will support their research and development efforts in the femtech space.

Twogee Biotech is a Munich-based biotechnology startup that specializes in tailor-made enzyme solutions for the industrial conversion of biomass into sustainable raw materials. The company focuses on transforming low-value biomass residues into high-value second-generation raw materials, enabling circular economy principles in the chemical industry.

Onos is a company focused on leveraging artificial intelligence to improve behavioral health payer processes. Their technology aims to enhance the efficiency and effectiveness of mental health services, addressing a critical need in the healthcare market. The recent funding will help them expand their capabilities and reach more clients.

Even Healthcare is a healthtech startup focused on expanding its managed-care hospital network and enhancing integrated healthcare delivery. The company aims to leverage digital technologies, including AI-powered tools, to improve healthcare services and telemedicine capabilities.

Metriport is a company that provides an open-source healthcare data infrastructure and point-of-care clinical intelligence capabilities. It aims to address fragmented patient data by giving clinicians faster access to complete medical histories across different healthcare organizations. The platform integrates records from various healthcare sources and enhances them with AI-powered tools for better clinical decision-making.

Clementine is a Netherlands-based healthtech startup that leverages AI-driven audiology software to automate diagnostic assessments and streamline patient triage. The platform aims to assist audiologists with personalized hearing-aid fittings, making high-quality hearing health more accessible across Europe.

Solace Care is a Stockholm-based end-of-life platform that helps users put their affairs in order while they still can and guides their families through the practical and emotional work that follows a death. The company aims to redefine personal insurance by providing support beyond just financial payouts, ensuring families receive assistance during difficult times.

Qure.ai is a global healthcare AI company that specializes in using artificial intelligence to enhance diagnostic processes and screening in healthcare. The company aims to expand its presence in the US market and invest in foundational AI models and acquisitions of complementary medical technology companies.